Cita APA

Kleijn, A., Kloezeman, J., Treffers-Westerlaken, E., Fulci, G., Leenstra, S., Dirven, C., . . . Lamfers, M. (2014). The therapeutic efficacy of the oncolytic virus Delta24-RGD in a murine glioma model depends primarily on antitumor immunity. Oncoimmunology.

Chicago Style Citation

Kleijn, Anne, Jenneke Kloezeman, Elike Treffers-Westerlaken, Giulia Fulci, Sieger Leenstra, Clemens Dirven, Reno Debets, i Martine Lamfers. "The Therapeutic Efficacy of the Oncolytic Virus Delta24-RGD in a Murine Glioma Model Depends Primarily On Antitumor Immunity." Oncoimmunology 2014.

Cita MLA

Kleijn, Anne, et al. "The Therapeutic Efficacy of the Oncolytic Virus Delta24-RGD in a Murine Glioma Model Depends Primarily On Antitumor Immunity." Oncoimmunology 2014.